|Subscribe NowLogin
Ground News Logo
Mar 03, 2021SUBSCRIBE NOW

Maryland Expands Phase 1 COVID Vaccine Eligibility For Severely Immunocompromised Marylanders

ANNAPOLIS (WJZ) — Maryland will expand Phase 1 eligibility for some immunocompromised Marylanders starting next week. The new groups added to Phase 1 starting February 1 include cancer patients in active treatment, end-stage renal disease requiring hemodialysis, chronic obstructive pulmonary disease, solid organ transplant patients–recipients– and those with sickle cell disease and diabetes.They will be able to get the vaccine through their hosp…
Maryland Expands Phase 1 COVID Vaccine Eligibility For Severely Immunocompromised Marylanders
1 month agoTampa, United States

BIAS DISTRIBUTION

C 100%
CBS Local
Maryland Expands Phase 1 COVID Vaccine Eligibility For Severely Immunocompromised Marylanders

Maryland Expands Phase 1 COVID Vaccine Eligibility For Severely Immunocompromised Marylanders

1 month ago|Tampa, United States

ANNAPOLIS (WJZ) — Maryland will expand Phase 1 eligibility for some immunocompromised Marylanders starting next week. The new groups added to Phase 1 starting February 1 include cancer patients in active treatment, end-stage renal disease requiring hemodialysis, chronic obstructive pulmonary disease, solid organ transplant patients–recipients– and those with sickle cell disease and diabetes.They will be able to get the vaccine through their hosp…

Coverage analysis

C 100%
CBS Local
This report's coverage is more Left.  Share it to spread the word.

Full Coverage

ARTICLES

Articles

Filters
Hide Duplicates
Sort by
CBS Local
CBS LocalL
1 month ago|United States

Maryland Expands Phase 1 COVID Vaccine Eligibility For Severely Immunocompromised Marylanders

ANNAPOLIS (WJZ) — Maryland will expand Phase 1 eligibility for some immunocompromised Marylanders starting next week. The new groups added to Phase 1 starting February 1 include cancer patients in active treatment, end-stage renal disease requiring hemodialysis, chronic obstructive pulmonary disease, solid organ transplant patients–recipients– and those with sickle cell disease and diabetes.They will be able to get the vaccine through their hosp…

1 month ago|United States
WFLA-TV
WFLA-TV
1 month ago|

Skin cancer vaccine developed by Tampa company enters Phase 1 of clinical trial

TAMPA, Fla. (WFLA) - A skin cancer vaccine developed by a Tampa company is entering "phase one" of clinical trials.Morphogenesis, Inc. completed its first-in-human phase one trial in cutaneous melanoma at Moffitt Cancer Center within the past year and has now moved into studying patients in earlier stages of skin cancers.The company will initiative phase one of the trial of "IFx-Hu2.0" for treating these stages. The vaccine contains a bacterial …

1 month ago|
TOPICS
SIMILAR STORIES
DETAILS
Total News Sources2Leaning Left1 sourceLeaning Right0 sourcesCenter0 sources